MolMed Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
223
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
1
MolMed General Information
Description
Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validation of innovative therapies to treat cancer. The company's therapies include TK for blood cancers and NGR-hTNF for solid tumors. Its pipeline includes antitumor therapeutics in clinical and preclinical development.
Contact Information
Website
www.molmed.comCorporate Office
- Via Olgettina 58
- 20132 Milan
- Italy
Corporate Office
- Via Olgettina 58
- 20132 Milan
- Italy
MolMed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MolMed Comparisons
Industry
Financing
Details
MolMed Competitors (1)
One of MolMed’s competitors is Agios Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agios Pharmaceuticals | Formerly VC-backed | Cambridge, MA |
MolMed Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MolMed Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MolMed Acquisitions (1)
MolMed’s most recent deal was a Merger/Acquisition with GenEra.. The deal was made on 01-Jan-2002.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GenEra. | 01-Jan-2002 | Merger/Acquisition | Biotechnology |
MolMed FAQs
-
When was MolMed founded?
MolMed was founded in 1996.
-
Where is MolMed headquartered?
MolMed is headquartered in Milan, Italy.
-
What is the size of MolMed?
MolMed has 223 total employees.
-
What industry is MolMed in?
MolMed’s primary industry is Biotechnology.
-
Is MolMed a private or public company?
MolMed is a Private company.
-
What is the current valuation of MolMed?
The current valuation of MolMed is .
-
What is MolMed’s current revenue?
The current revenue for MolMed is .
-
How much funding has MolMed raised over time?
MolMed has raised $184M.
-
Who are MolMed’s investors?
Delfin, EDCP venture capital, Finanziaria d'investimento Fininvest, H Equity Partners, and Intesa Sanpaolo are 5 of 7 investors who have invested in MolMed.
-
Who are MolMed’s competitors?
Agios Pharmaceuticals is a competitor of MolMed.
-
When was MolMed acquired?
MolMed was acquired on 31-Jul-2020.
-
Who acquired MolMed?
MolMed was acquired by AGC Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
